Alnylam Pharmaceuticals Market Sentiment

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$248.68

1.170.47%

À la clôture: Sep 11, 5:00 PM EST

$255.00

6.322.54%

Après les heures: 5:18 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.3% short float

Options Flow▲ 0.92 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

0.92

More calls — Bullish

857 calls · 792 puts

Avg Consensus PT

$419

+64.2%

Highest Price Target

$583

+128.6%

Citigroup

Lowest Price Target

$256

+0.4%

Wells Fargo

Short Interest

6.3%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 8, 2026	Jefferies	Faisal Khurshid—	+2.0%	$230 → $260	Maintained	Hold
Sep 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+78.4%	$455 → $455	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+24.7%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	+0.4%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+23.5%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+78.4%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+64.7%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+33.3%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+76.5%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+47.1%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+37.3%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+17.6%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+37.3%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+23.9%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+24.7%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+66.7%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+40.0%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+56.9%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+60.8%	$460 → $410	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+60.8%	$505 → $410	Maintained	Buy
Jul 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+90.2%	$470 → $485	Maintained	Buy
Jul 10, 2026	Morgan Stanley	Michael Ulz—	+56.9%	$370 → $400	Maintained	Equal-Weight
Jun 29, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+84.3%	$510 → $470	Maintained	Buy
Jun 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+100.0%	$510 → $510	Maintained	Buy
May 19, 2026	Citigroup	Eric Joseph—	+49.0%	$380	Initiate	Buy